Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory markers in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies
Xue‐Ning Shen, Li‐Dong Niu, Yan‐Jiang Wang, et al.
Journal of Neurology Neurosurgery & Psychiatry (2019) Vol. 90, Iss. 5, pp. 590-598
Closed Access | Times Cited: 315

Showing 1-25 of 315 citing articles:

The landscape of cognitive function in recovered COVID-19 patients
Hetong Zhou, Shaojia Lu, Jingkai Chen, et al.
Journal of Psychiatric Research (2020) Vol. 129, pp. 98-102
Open Access | Times Cited: 412
Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies
Henrik Zetterberg, Barbara B. Bendlin
Molecular Psychiatry (2020) Vol. 26, Iss. 1, pp. 296-308
Open Access | Times Cited: 291
Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus
Brianne M. Bettcher, Malú G. Tansey, Guillaume Dorothée, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 11, pp. 689-701
Open Access | Times Cited: 285
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Junling Yang, Leslie Wise, Ken‐ichiro Fukuchi
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 275
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
Harald Hampel, Filippo Caraci, A. Claudio Cuello, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 266
Psychiatric face of COVID-19
Luca Steardo, Luca Steardo, Alexei Verkhratsky
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 212
Alzheimer’s Disease: An Update and Insights Into Pathophysiology
Murtala Bello Abubakar, Kamaldeen Olalekan Sanusi, Azizah Ugusman, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 162
Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia
Jennifer Frontera, Allal Boutajangout, Arjun V. Masurkar, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 5, pp. 899-910
Open Access | Times Cited: 130
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life
Sara Poletti, Mariagrazia Palladini, Mario Gennaro Mazza, et al.
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 272, Iss. 5, pp. 773-782
Open Access | Times Cited: 118
Connecting aging biology and inflammation in the omics era
Keenan A. Walker, Nathan Basisty, David M. Wilson, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 14
Open Access | Times Cited: 109
Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
Donovan McGrowder, Fabian Miller, Kurt Vaz, et al.
Brain Sciences (2021) Vol. 11, Iss. 2, pp. 215-215
Open Access | Times Cited: 108
Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
Nour F. Al-Ghraiybah, Junwei Wang, Amer E. Alkhalifa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10572-10572
Open Access | Times Cited: 92
Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 78
Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders
Аnna Morozova, Yana Zorkina, Olga Abramova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1217-1217
Open Access | Times Cited: 70
Association of inflammation and cognition in the elderly: A systematic review and meta-analysis
Sofia Leonardo, Felipe Fregni
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 59
Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study
Dong Ji, Wen-Zhu Chen, Lei Zhang, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 54
The role of peripheral inflammatory insults in Alzheimer’s disease: a review and research roadmap
Keenan A. Walker, Lydia M. Le Page, Niccolò Terrando, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 49
C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians
Dimitra S. Mouliou
Diseases (2023) Vol. 11, Iss. 4, pp. 132-132
Open Access | Times Cited: 48
Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis
Futao Zhou, Yangyan Sun, Xinhua Xie, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 42
The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies
Suhrud Pathak, Rishi Nadar, Shannon Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 853-853
Open Access | Times Cited: 30
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
Wendy Balestri, Ruchi Sharma, Victor Allisson da Silva, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer’s and Parkinson’s disease
Niklas Reich, Christian Hölscher
Frontiers in Neuroendocrinology (2024) Vol. 73, pp. 101122-101122
Open Access | Times Cited: 16
The investigation of peripheral inflammatory and oxidative stress biomarkers in dementia with Lewy Bodies, compared with Alzheimer’s Disease, and mild cognitive impairment
Yueyi Yu, Huixin Shen, Qi Qin, et al.
Neuroscience (2025)
Closed Access | Times Cited: 2
Effects of Folic Acid and Vitamin B12 Supplementation on Cognitive Impairment and Inflammation in Patients with Alzheimer’s Disease: A Randomized, Single-Blinded, Placebo-Controlled Trial
H. Chen, S. Liu, Baojin Ge, et al.
The Journal of Prevention of Alzheimer s Disease (2021), pp. 1-8
Closed Access | Times Cited: 86
Role of interleukin 8 in depression and other psychiatric disorders
Shih‐Jen Tsai
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110173-110173
Closed Access | Times Cited: 80
Page 1 - Next Page

Scroll to top